Stanley Laman Group, Ltd. Synlogic, Inc. Transaction History

Stanley Laman Group, Ltd.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 09, 2018	SELL	$9.01 - $13.33 $239,206 - $353,898	-26,549 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$9.38 - $12.12 $249,029 - $321,773	26,549 New	26,549 $249,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.